IL-33 drives the antitumour effects of dendritic cells via upregulating CYLD expression in pulmonary adenocarcinoma
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
IL-33 drives the antitumour effects of dendritic cells via upregulating CYLD expression in pulmonary adenocarcinoma
Authors
Keywords
-
Journal
Artificial Cells Nanomedicine and Biotechnology
Volume 47, Issue 1, Pages 1335-1341
Publisher
Informa UK Limited
Online
2019-04-09
DOI
10.1080/21691401.2019.1596926
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Downregulation of Membrane Trafficking Proteins and Lactate Conditioning Determine Loss of Dendritic Cell Function in Lung Cancer
- (2018) Nicoletta Caronni et al. CANCER RESEARCH
- Lower expression level of IL-33 is associated with poor prognosis of pulmonary adenocarcinoma
- (2018) Min Yang et al. PLoS One
- Dendritic cell activation enhances anti-PD-1 mediated immunotherapy against glioblastoma
- (2018) Tomas Garzon-Muvdi et al. Oncotarget
- Interleukin 33 Signaling Restrains Sporadic Colon Cancer in an Interferon-γ–Dependent Manner
- (2018) Moritz F. Eissmann et al. Cancer Immunology Research
- Interleukin-33 Receptor (ST2) Deficiency Improves the Outcome of Staphylococcus aureus-Induced Septic Arthritis
- (2018) Larissa Staurengo-Ferrari et al. Frontiers in Immunology
- IL-33 promotes recovery from acute colitis by inducing miR-320 to stimulate epithelial restitution and repair
- (2018) Loris R. Lopetuso et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Rsad2 is necessary for mouse dendritic cell maturation via the IRF7-mediated signaling pathway
- (2018) Ji-Su Jang et al. Cell Death & Disease
- Chitin promotes antigen-specific Th2 cell-mediated murine asthma through induction of IL-33-mediated IL-1β production by DCs
- (2018) Ken Arae et al. Scientific Reports
- Interleukin-33 Contributes to the Induction of Th9 Cells and Antitumor Efficacy by Dectin-1-Activated Dendritic Cells
- (2018) Jintong Chen et al. Frontiers in Immunology
- Regulatory Mechanisms of IL-33-ST2-Mediated Allergic Inflammation
- (2018) Hiroaki Takatori et al. Frontiers in Immunology
- Alternative Splice Forms of CYLD Mediate Ubiquitination of SMAD7 to Prevent TGFB Signaling and Promote Colitis
- (2018) Yilang Tang et al. GASTROENTEROLOGY
- Exosomes Released from Tumor-Associated Macrophages Transfer miRNAs That Induce a Treg/Th17 Cell Imbalance in Epithelial Ovarian Cancer
- (2018) Jieru Zhou et al. Cancer Immunology Research
- Novel “Elements” of Immune Suppression within the Tumor Microenvironment
- (2017) Devikala Gurusamy et al. Cancer Immunology Research
- IL-33 restricts tumor growth and inhibits pulmonary metastasis in melanoma-bearing mice through eosinophils
- (2017) Valeria Lucarini et al. OncoImmunology
- STAT3 and NF-κB are Simultaneously Suppressed in Dendritic Cells in Lung Cancer
- (2017) Rui Li et al. Scientific Reports
- Exogenous IL-33 Restores Dendritic Cell Activation and Maturation in Established Cancer
- (2016) Donye Dominguez et al. JOURNAL OF IMMUNOLOGY
- Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBPα expression
- (2016) Kol Jia Yong et al. Science Translational Medicine
- CYLD Proteolysis Protects Macrophages from TNF-Mediated Auto-necroptosis Induced by LPS and Licensed by Type I IFN
- (2016) Diana Legarda et al. Cell Reports
- Anti-CD40-induced inflammatory E-cadherin+ dendritic cells enhance T cell responses and antitumour immunity in murine Lewis lung carcinoma
- (2015) Yong Zhang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity
- (2015) Yaron Carmi et al. NATURE
- CYLD Regulates Noscapine Activity in Acute Lymphoblastic Leukemia via a Microtubule-Dependent Mechanism
- (2015) Yunfan Yang et al. Theranostics
- Interleukin 33 in tumor microenvironment is crucial for the accumulation and function of myeloid-derived suppressor cells
- (2015) Peng Xiao et al. OncoImmunology
- Transgenic expression of IL-33 activates CD8+ T cells and NK cells and inhibits tumor growth and metastasis in mice
- (2013) Kun Gao et al. CANCER LETTERS
- CYLD controls c-MYC expression through the JNK-dependent signaling pathway in hepatocellular carcinoma
- (2013) Rajeswara Rao Pannem et al. CARCINOGENESIS
- Innate and adaptive immune cells in the tumor microenvironment
- (2013) Thomas F Gajewski et al. NATURE IMMUNOLOGY
- Dysregulation of TNFα-induced necroptotic signaling in chronic lymphocytic leukemia: suppression of CYLD gene by LEF1
- (2011) P Liu et al. LEUKEMIA
- CYLD regulates keratinocyte differentiation and skin cancer progression in humans
- (2011) J P Alameda et al. Cell Death & Disease
- Naturally occurring short splice variant of CYLD positively regulates dendritic cell function
- (2009) C. C. Srokowski et al. BLOOD
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started